Cresco Labs CEO Discusses Illinois Market, Origin House Synergies, and Opportunities in Florida

Capital 10X interviews Cresco Labs [stock_market_widget type="inline" template="generic" color="default" assets="CL.CN" markup="(CSE: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] CEO Charlie Bachtell after an exciting series of developments for the MSO.

They discuss the newly legalized Illinois market, including the supply challenges facing the different players in the space. As Bachtell details, Cresco Labs is well situated with a large cultivation footprint and distribution network.

He also elaborates on the Origin House acquisition now that it has closed, detailing the value they bring to Cresco and the opportunities for synergistic cost reductions.

Finally, he discusses the canceling of the VidaCann acquisition and why they are still evaluating opportunities in the Florida market.

0 0 votes
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Evan Veryard has a Bachelor's of Chemical Engineering from McGill University and a MaSc. of Chemical Engineering from RMC. He has over 6 years of research experience focusing on industrial materials. Address: 682 Indian Road, Toronto, Ontario, M6P 2C9. Phone: 416-721-8257.
Notify of
Inline Feedbacks
View all comments